Omeprazole, clarithromycin and furazolidone for the eradication of Helicobacter pylori in patients with duodenal ulcer.

Author: CabralM M, DaniR, De CastroL P, DiasM G, FrancoJ M, MagalhãesL C, MendesG S, MoreiraL S, QueirozD M, RochaG A, SallesP G, ToppaN H

Paper Details 
Original Abstract of the Article :
AIM: To evaluate the efficacy of omeprazole plus clarithromycin and furazolidone in Helicobacter pylori eradication and duodenal ulcer healing in Brazilian patients. METHODS: Forty H. pylori-positive patients with duodenal ulcer were randomized to receive 20 mg omeprazole o.m. or b.d. for 1 month p...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1046/j.1365-2036.1999.00653.x

データ提供:米国国立医学図書館(NLM)

Eradicating Helicobacter pylori: A Trio of Drugs Shows Promise

Helicobacter pylori (H. pylori) is a common bacterium that can cause ulcers and other digestive problems. This study investigates the efficacy of a combination of omeprazole, clarithromycin, and furazolidone in eradicating H. pylori and healing duodenal ulcers in Brazilian patients.

The researchers conducted a randomized trial involving 40 patients with H. pylori-positive duodenal ulcers. The participants were treated with omeprazole, clarithromycin, and furazolidone for varying durations. The study found that the combination of these three drugs achieved a high eradication rate, with a success rate of 90% by intention-to-treat analysis and 97% by per protocol analysis.

A Powerful Trio for Stomach Health

This study suggests that this triple therapy regimen could be a valuable option for treating H. pylori infections and promoting ulcer healing. The high eradication rates achieved in this study are encouraging, potentially leading to improved patient outcomes and a reduction in the prevalence of H. pylori infections.

Fighting Stomach Troubles with a Trio of Drugs

This research is like a camel caravan carrying a valuable treasure – a combination of drugs that can effectively combat H. pylori infections.

Dr. Camel's Conclusion

This study is like a camel caravan carrying a precious cargo of healing – a combination of drugs that could effectively eradicate H. pylori and bring relief to those suffering from stomach problems.

Date :
  1. Date Completed 2000-02-10
  2. Date Revised 2019-08-31
Further Info :

Pubmed ID

10594400

DOI: Digital Object Identifier

10.1046/j.1365-2036.1999.00653.x

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.